StarkKMathurAKhanMM. Anticoagulation in venous thromboembolism for the general physician. J R Coll Phys Edinburgh2024; 54: 74–83.
2.
RobertsLNAryaRHuntBJ. Advances and current research in primary thromboprophylaxis to prevent hospital-associated venous thromboembolism. Brit J Haematol2024; 204: 1635–48.
3.
EckRJEllingTSuttonAJ, et al. Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis. BMJ2022; 378: e070022.
4.
NeumannIIzcovichAZhangY, et al. DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines. Blood Adv2020; 4: 1512–17.
5.
KatoSTakahashiKAyabeK, et al. Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients. Brit J Haematol2011; 154: 373–7.
6.
NemethBDouilletDLe CessieS, et al. Clinical risk assessment model to predict venous thromboembolism risk after immobilization for lower-limb trauma. EClinicalMedicine2020; 20: 100270.
7.
GailaniDGruberA. Targeting Factor XI and Factor XIa to prevent thrombosis. Blood2024; 143: 1465–75.
